[引用][C] Microbiological and clinical profile of uropathogenic Escherichia coli isolates in Kathmandu university hospital
JB Sherchan, P Gurung, P Karkee… - Journal of Nepal …, 2016 - jnhrc.com.np
Background: Treatment of patients infected by multidrug resistant bacteria is a major
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …
[引用][C] Microbiological and Clinical Profile of Uropathogenic Escherichia coli Isolates in Kathmandu University Hospital
JB Sherchan, P Gurung, P Karkee… - Journal of Nepal …, 2016 - jnhrc.com.np
Background: Treatment of patients infected by multidrug resistant bacteria is a major
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …
Microbiological and Clinical Profile of Uropathogenic Escherichia coli Isolates in Kathmandu University Hospital
JB Sherchan, P Gurung, P Karkee… - Journal of Nepal …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Treatment of patients infected by multidrug resistant bacteria is a major
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …
Microbiological and Clinical Profile of Uropathogenic Escherichia coli Isolates in Kathmandu University Hospital.
JB Sherchan, P Gurung, P Karkee… - Journal of Nepal …, 2016 - europepmc.org
Background Treatment of patients infected by multidrug resistant bacteria is a major
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …
challenge. Immunocompromised status, prolonged hospital stay, malignancy, diabetes are …